BIOFRONTERA |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.298 EUR | -12.87% |
|
-.--% | -.--% |
| 24/06 | Biofrontera Announces the Launch of A New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp | CI |
| 31/05 | Biofrontera AG Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOFRONTERA | Other Pharmaceuticals | -12.87% | -.--% | - | - | - | 1.94Cr | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- B8FK Stock
- B8F Stock
- Charts Biofrontera
- Comparison Chart
